Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

D(2) dopamine receptor (Dopamine D2 receptor)

 DRD2_RAT                Reviewed;         444 AA.
P61169; P13953;
10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
10-MAY-2004, sequence version 1.
27-SEP-2017, entry version 130.
RecName: Full=D(2) dopamine receptor;
AltName: Full=Dopamine D2 receptor;
Name=Drd2;
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
NCBI_TaxID=10116;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
TISSUE=Brain;
PubMed=2974511; DOI=10.1038/336783a0;
Bunzow J.R., van Tol H.H.M., Grandy D.K., Albert P., Salon J.,
Christie M., Machida C.A., Neve K.A., Civelli O.;
"Cloning and expression of a rat D2 dopamine receptor cDNA.";
Nature 336:783-787(1988).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2531846; DOI=10.1038/342865a0;
Eidne K.A., Taylor P.L., Zabavnik J., Saunders P.T.K., Inglis J.D.;
"D2 receptor, a missing exon.";
Nature 342:865-865(1989).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2531847; DOI=10.1038/342923a0;
Giros B., Sokoloff P., Martres M.-P., Riou J.-F., Emorine L.J.,
Schwartz J.-C.;
"Alternative splicing directs the expression of two D2 dopamine
receptor isoforms.";
Nature 342:923-926(1989).
[4]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2480527; DOI=10.1038/342926a0;
Monsma F.J. Jr., McVittie L.D., Gerfen C.R., Mahan L.C., Sibley D.R.;
"Multiple D2 dopamine receptors produced by alternative RNA
splicing.";
Nature 342:926-929(1989).
[5]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2139615; DOI=10.1016/0014-5793(90)80695-F;
Rao D.D., McKelvy J., Kebabian J., MacKenzie R.G.;
"Two forms of the rat D2 dopamine receptor as revealed by the
polymerase chain reaction.";
FEBS Lett. 263:18-22(1990).
[6]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
STRAIN=Sprague-Dawley;
Taylor P.L., Inglis J.D., Eidne K.A.;
"5'untranslated region of rat pituitary dopamine D2(B) receptor
contains a putative CpG island.";
Submitted (OCT-1990) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [MRNA] OF 242-270.
PubMed=2137336; DOI=10.1016/0006-291X(90)91917-H;
Miller J.C., Wang Y., Filer D.;
"Identification by sequence analysis of a second rat brain cDNA
encoding the dopamine (D2) receptor.";
Biochem. Biophys. Res. Commun. 166:109-112(1990).
[8]
NUCLEOTIDE SEQUENCE [MRNA] OF 242-270.
PubMed=2138567; DOI=10.1016/0014-5793(90)80140-E;
O'Dowd B.F., Nguyen T., Tirpak A., Jarvie K.R., Israel Y., Seeman P.,
Niznik H.B.;
"Cloning of two additional catecholamine receptors from rat brain.";
FEBS Lett. 262:8-12(1990).
[9]
MUTAGENESIS OF SER-193; SER-194; SER-197 AND SER-420.
PubMed=1321233; DOI=10.1111/j.1471-4159.1992.tb09416.x;
Cox B.A., Henningsen R.A., Spanoyannis A., Neve R.L., Neve K.A.;
"Contributions of conserved serine residues to the interactions of
ligands with dopamine D2 receptors.";
J. Neurochem. 59:627-635(1992).
[10]
INTERACTION WITH PPP1R9B.
PubMed=10391935; DOI=10.1074/jbc.274.28.19894;
Smith F.D., Oxford G.S., Milgram S.L.;
"Association of the D2 dopamine receptor third cytoplasmic loop with
spinophilin, a protein phosphatase-1-interacting protein.";
J. Biol. Chem. 274:19894-19900(1999).
[11]
INTERACTION WITH CLIC6.
PubMed=14499480; DOI=10.1016/S0169-328X(03)00283-3;
Griffon N., Jeanneteau F., Prieur F., Diaz J., Sokoloff P.;
"CLIC6, a member of the intracellular chloride channel family,
interacts with dopamine D(2)-like receptors.";
Brain Res. Mol. Brain Res. 117:47-57(2003).
[12]
INTERACTION WITH GPRASP1.
PubMed=16049099; DOI=10.1073/pnas.0502418102;
Bartlett S.E., Enquist J., Hopf F.W., Lee J.H., Gladher F.,
Kharazia V., Waldhoer M., Mailliard W.S., Armstrong R., Bonci A.,
Whistler J.L.;
"Dopamine responsiveness is regulated by targeted sorting of D2
receptors.";
Proc. Natl. Acad. Sci. U.S.A. 102:11521-11526(2005).
[13]
INTERACTION WITH ARRB2.
PubMed=19332542; DOI=10.1074/jbc.M900388200;
Namkung Y., Dipace C., Javitch J.A., Sibley D.R.;
"G protein-coupled receptor kinase-mediated phosphorylation regulates
post-endocytic trafficking of the D2 dopamine receptor.";
J. Biol. Chem. 284:15038-15051(2009).
[14]
3D-STRUCTURE MODELING.
PubMed=1358063; DOI=10.1042/bj2870277;
Livingstone C.D., Strange P.G., Naylor L.H.;
"Molecular modelling of D2-like dopamine receptors.";
Biochem. J. 287:277-282(1992).
-!- FUNCTION: Dopamine receptor whose activity is mediated by G
proteins which inhibit adenylyl cyclase.
{ECO:0000269|PubMed:1321233}.
-!- SUBUNIT: Forms homo- and heterooligomers with DRD4. The
interaction with DRD4 may modulate agonist-induced downstream
signaling (By similarity). Interacts with HTR2A, CADPS and CADPS2
(By similarity). Interacts with KCNA2 (By similarity). Interacts
with GPRASP1, PPP1R9B and CLIC6. Interacts with ARRB2.
{ECO:0000250|UniProtKB:P14416, ECO:0000250|UniProtKB:P61168,
ECO:0000269|PubMed:10391935, ECO:0000269|PubMed:14499480,
ECO:0000269|PubMed:16049099, ECO:0000269|PubMed:19332542}.
-!- INTERACTION:
O35274:Ppp1r9b; NbExp=2; IntAct=EBI-80012, EBI-80022;
-!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=Long;
IsoId=P61169-1, P13953-1;
Sequence=Displayed;
Name=Short;
IsoId=P61169-2, P13953-2;
Sequence=VSP_001871;
-!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
{ECO:0000255|PROSITE-ProRule:PRU00521}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; M36831; AAA41075.1; -; mRNA.
EMBL; X53278; CAA37373.1; -; mRNA.
EMBL; X56065; CAA39543.1; -; mRNA.
EMBL; M32241; AAA41074.1; -; mRNA.
PIR; S08146; S08146.
RefSeq; NP_036679.1; NM_012547.1. [P61169-1]
RefSeq; XP_006243041.1; XM_006242979.3. [P61169-2]
UniGene; Rn.87299; -.
ProteinModelPortal; P61169; -.
BioGrid; 246498; 5.
CORUM; P61169; -.
DIP; DIP-30883N; -.
IntAct; P61169; 3.
MINT; MINT-4792453; -.
BindingDB; P61169; -.
ChEMBL; CHEMBL339; -.
GuidetoPHARMACOLOGY; 215; -.
iPTMnet; P61169; -.
PhosphoSitePlus; P61169; -.
PRIDE; P61169; -.
Ensembl; ENSRNOT00000045944; ENSRNOP00000043759; ENSRNOG00000008428. [P61169-1]
Ensembl; ENSRNOT00000083419; ENSRNOP00000074235; ENSRNOG00000008428. [P61169-2]
GeneID; 24318; -.
KEGG; rno:24318; -.
UCSC; RGD:2520; rat.
CTD; 1813; -.
RGD; 2520; Drd2.
GeneTree; ENSGT00760000118795; -.
HOGENOM; HOG000239242; -.
HOVERGEN; HBG106962; -.
InParanoid; P61169; -.
KO; K04145; -.
OMA; RNWSRPF; -.
OrthoDB; EOG091G06VI; -.
PhylomeDB; P61169; -.
TreeFam; TF334382; -.
Reactome; R-RNO-390651; Dopamine receptors.
Reactome; R-RNO-418594; G alpha (i) signalling events.
PRO; PR:P61169; -.
Proteomes; UP000002494; Chromosome 8.
Bgee; ENSRNOG00000008428; -.
Genevisible; P61169; RN.
GO; GO:0001669; C:acrosomal vesicle; IDA:RGD.
GO; GO:0030424; C:axon; IDA:RGD.
GO; GO:0043679; C:axon terminus; IDA:RGD.
GO; GO:0005623; C:cell; IEA:GOC.
GO; GO:0060170; C:ciliary membrane; IEA:Ensembl.
GO; GO:0031410; C:cytoplasmic vesicle; IDA:RGD.
GO; GO:0030425; C:dendrite; IDA:RGD.
GO; GO:0043197; C:dendritic spine; IDA:RGD.
GO; GO:0030139; C:endocytic vesicle; IDA:RGD.
GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
GO; GO:0016328; C:lateral plasma membrane; IDA:RGD.
GO; GO:0016020; C:membrane; IDA:BHF-UCL.
GO; GO:0097730; C:non-motile cilium; IEA:Ensembl.
GO; GO:0043204; C:perikaryon; IDA:RGD.
GO; GO:0005886; C:plasma membrane; IDA:RGD.
GO; GO:0014069; C:postsynaptic density of dendrite; IDA:RGD.
GO; GO:0036126; C:sperm flagellum; IDA:RGD.
GO; GO:0030672; C:synaptic vesicle membrane; IDA:RGD.
GO; GO:0035240; F:dopamine binding; IMP:RGD.
GO; GO:0004952; F:dopamine neurotransmitter receptor activity; IMP:RGD.
GO; GO:0001591; F:dopamine neurotransmitter receptor activity, coupled via Gi/Go; IDA:BHF-UCL.
GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
GO; GO:0046982; F:protein heterodimerization activity; IPI:RGD.
GO; GO:0042803; F:protein homodimerization activity; IDA:RGD.
GO; GO:0005102; F:receptor binding; IPI:RGD.
GO; GO:0046717; P:acid secretion; IDA:BHF-UCL.
GO; GO:0032147; P:activation of protein kinase activity; IDA:RGD.
GO; GO:0021984; P:adenohypophysis development; IEA:Ensembl.
GO; GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IDA:BHF-UCL.
GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IDA:RGD.
GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
GO; GO:0050482; P:arachidonic acid secretion; IEA:Ensembl.
GO; GO:0031223; P:auditory behavior; IMP:RGD.
GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
GO; GO:0048148; P:behavioral response to cocaine; IBA:GO_Central.
GO; GO:0048149; P:behavioral response to ethanol; IBA:GO_Central.
GO; GO:0048755; P:branching morphogenesis of a nerve; IEA:Ensembl.
GO; GO:0030007; P:cellular potassium ion homeostasis; IC:BHF-UCL.
GO; GO:0021853; P:cerebral cortex GABAergic interneuron migration; IEA:Ensembl.
GO; GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl.
GO; GO:0042417; P:dopamine metabolic process; IEA:Ensembl.
GO; GO:0007212; P:dopamine receptor signaling pathway; IDA:RGD.
GO; GO:0007631; P:feeding behavior; IEA:Ensembl.
GO; GO:0030900; P:forebrain development; IMP:RGD.
GO; GO:0002031; P:G-protein coupled receptor internalization; IDA:RGD.
GO; GO:0007625; P:grooming behavior; IEA:Ensembl.
GO; GO:0007626; P:locomotory behavior; IMP:RGD.
GO; GO:0007616; P:long-term memory; IMP:RGD.
GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:RGD.
GO; GO:0007194; P:negative regulation of adenylate cyclase activity; IDA:BHF-UCL.
GO; GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl.
GO; GO:0030336; P:negative regulation of cell migration; IEA:Ensembl.
GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
GO; GO:0042321; P:negative regulation of circadian sleep/wake cycle, sleep; IDA:RGD.
GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IMP:RGD.
GO; GO:0060160; P:negative regulation of dopamine receptor signaling pathway; IEA:Ensembl.
GO; GO:0033602; P:negative regulation of dopamine secretion; IMP:RGD.
GO; GO:0045824; P:negative regulation of innate immune response; IEA:Ensembl.
GO; GO:0046676; P:negative regulation of insulin secretion; IMP:RGD.
GO; GO:0051898; P:negative regulation of protein kinase B signaling; IEA:Ensembl.
GO; GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IBA:GO_Central.
GO; GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:BHF-UCL.
GO; GO:0001976; P:neurological system process involved in regulation of systemic arterial blood pressure; IEA:Ensembl.
GO; GO:0007270; P:neuron-neuron synaptic transmission; IEA:Ensembl.
GO; GO:0021769; P:orbitofrontal cortex development; IEP:RGD.
GO; GO:0030432; P:peristalsis; IEA:Ensembl.
GO; GO:0046488; P:phosphatidylinositol metabolic process; IDA:BHF-UCL.
GO; GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:GO_Central.
GO; GO:0043473; P:pigmentation; IEA:Ensembl.
GO; GO:0032467; P:positive regulation of cytokinesis; IEA:Ensembl.
GO; GO:0051586; P:positive regulation of dopamine uptake involved in synaptic transmission; IEA:Ensembl.
GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
GO; GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IMP:RGD.
GO; GO:1900168; P:positive regulation of glial cell-derived neurotrophic factor secretion; IEA:Ensembl.
GO; GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl.
GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
GO; GO:0045840; P:positive regulation of mitotic nuclear division; TAS:BHF-UCL.
GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
GO; GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl.
GO; GO:0002092; P:positive regulation of receptor internalization; IMP:RGD.
GO; GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:RGD.
GO; GO:0035810; P:positive regulation of urine volume; IEA:Ensembl.
GO; GO:0060134; P:prepulse inhibition; IEA:Ensembl.
GO; GO:0008104; P:protein localization; IEA:Ensembl.
GO; GO:0002027; P:regulation of heart rate; IEA:Ensembl.
GO; GO:0090325; P:regulation of locomotion involved in locomotory behavior; IMP:RGD.
GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl.
GO; GO:0043408; P:regulation of MAPK cascade; IDA:RGD.
GO; GO:0043666; P:regulation of phosphoprotein phosphatase activity; IMP:RGD.
GO; GO:0043266; P:regulation of potassium ion transport; IDA:BHF-UCL.
GO; GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl.
GO; GO:0051823; P:regulation of synapse structural plasticity; IDA:RGD.
GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.
GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:BHF-UCL.
GO; GO:0001975; P:response to amphetamine; IEP:RGD.
GO; GO:0048678; P:response to axon injury; IEP:RGD.
GO; GO:0042493; P:response to drug; IDA:BHF-UCL.
GO; GO:0045471; P:response to ethanol; IEP:RGD.
GO; GO:0034776; P:response to histamine; IEA:Ensembl.
GO; GO:0001666; P:response to hypoxia; IMP:RGD.
GO; GO:0014854; P:response to inactivity; IEP:RGD.
GO; GO:0010039; P:response to iron ion; IEP:RGD.
GO; GO:0043278; P:response to morphine; IEA:Ensembl.
GO; GO:0035094; P:response to nicotine; IEP:RGD.
GO; GO:0009636; P:response to toxic substance; IEP:RGD.
GO; GO:0007608; P:sensory perception of smell; IEA:Ensembl.
GO; GO:0021756; P:striatum development; IEP:RGD.
GO; GO:0007416; P:synapse assembly; IEP:BHF-UCL.
GO; GO:0001963; P:synaptic transmission, dopaminergic; IDA:RGD.
GO; GO:0001659; P:temperature homeostasis; IEA:Ensembl.
GO; GO:0008542; P:visual learning; IEA:Ensembl.
GO; GO:0016055; P:Wnt signaling pathway; IDA:RGD.
InterPro; IPR001922; Dopamine_D2_rcpt.
InterPro; IPR000929; Dopamine_rcpt.
InterPro; IPR000276; GPCR_Rhodpsn.
InterPro; IPR017452; GPCR_Rhodpsn_7TM.
Pfam; PF00001; 7tm_1; 1.
PRINTS; PR00567; DOPAMINED2R.
PRINTS; PR00242; DOPAMINER.
PRINTS; PR00237; GPCRRHODOPSN.
SMART; SM01381; 7TM_GPCR_Srsx; 1.
PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
1: Evidence at protein level;
Alternative splicing; Cell membrane; Complete proteome;
Disulfide bond; G-protein coupled receptor; Glycoprotein; Membrane;
Receptor; Reference proteome; Transducer; Transmembrane;
Transmembrane helix.
CHAIN 1 444 D(2) dopamine receptor.
/FTId=PRO_0000069390.
TOPO_DOM 1 37 Extracellular. {ECO:0000250}.
TRANSMEM 38 60 Helical; Name=1. {ECO:0000250}.
TOPO_DOM 61 70 Cytoplasmic. {ECO:0000250}.
TRANSMEM 71 93 Helical; Name=2. {ECO:0000250}.
TOPO_DOM 94 108 Extracellular. {ECO:0000250}.
TRANSMEM 109 130 Helical; Name=3. {ECO:0000250}.
TOPO_DOM 131 151 Cytoplasmic. {ECO:0000250}.
TRANSMEM 152 172 Helical; Name=4. {ECO:0000250}.
TOPO_DOM 173 188 Extracellular. {ECO:0000250}.
TRANSMEM 189 213 Helical; Name=5. {ECO:0000250}.
TOPO_DOM 214 374 Cytoplasmic. {ECO:0000250}.
TRANSMEM 375 396 Helical; Name=6. {ECO:0000250}.
TOPO_DOM 397 410 Extracellular. {ECO:0000250}.
TRANSMEM 411 432 Helical; Name=7. {ECO:0000250}.
TOPO_DOM 433 444 Cytoplasmic. {ECO:0000250}.
REGION 190 197 Agonist binding. {ECO:0000250}.
REGION 211 374 Interaction with PPP1R9B.
{ECO:0000269|PubMed:10391935}.
REGION 387 395 Agonist binding. {ECO:0000250}.
BINDING 114 114 Agonist. {ECO:0000250}.
SITE 194 194 Important for receptor activation.
SITE 197 197 Important for receptor activation.
CARBOHYD 5 5 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 17 17 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 23 23 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 107 182 {ECO:0000255|PROSITE-ProRule:PRU00521}.
DISULFID 400 402 {ECO:0000255|PROSITE-ProRule:PRU00521}.
VAR_SEQ 242 270 Missing (in isoform Short).
{ECO:0000303|PubMed:2974511}.
/FTId=VSP_001871.
MUTAGEN 193 193 S->A: Moderate decrease in ligand
binding. 200-fold reduction of agonist-
mediated cAMP inhibition.
{ECO:0000269|PubMed:1321233}.
MUTAGEN 194 194 S->A: Small decrease in agonist binding.
Complete loss of agonist-mediated cAMP
inhibition. {ECO:0000269|PubMed:1321233}.
MUTAGEN 197 197 S->A: Small decrease in agonist binding.
18-fold reduction of agonist-mediated
cAMP inhibition.
{ECO:0000269|PubMed:1321233}.
MUTAGEN 420 420 S->A: Moderate decrease in ligand
binding. {ECO:0000269|PubMed:1321233}.
CONFLICT 99 99 E -> D (in Ref. 5; CAA37373).
{ECO:0000305}.
CONFLICT 173 173 G -> R (in Ref. 5; CAA37373).
{ECO:0000305}.
CONFLICT 180 180 N -> G (in Ref. 5; CAA37373).
{ECO:0000305}.
SEQUENCE 444 AA; 50904 MW; 216E56CEE5CA32FB CRC64;
MDPLNLSWYD DDLERQNWSR PFNGSEGKAD RPHYNYYAML LTLLIFIIVF GNVLVCMAVS
REKALQTTTN YLIVSLAVAD LLVATLVMPW VVYLEVVGEW KFSRIHCDIF VTLDVMMCTA
SILNLCAISI DRYTAVAMPM LYNTRYSSKR RVTVMIAIVW VLSFTISCPL LFGLNNTDQN
ECIIANPAFV VYSSIVSFYV PFIVTLLVYI KIYIVLRKRR KRVNTKRSSR AFRANLKTPL
KGNCTHPEDM KLCTVIMKSN GSFPVNRRRM DAARRAQELE MEMLSSTSPP ERTRYSPIPP
SHHQLTLPDP SHHGLHSNPD SPAKPEKNGH AKIVNPRIAK FFEIQTMPNG KTRTSLKTMS
RRKLSQQKEK KATQMLAIVL GVFIICWLPF FITHILNIHC DCNIPPVLYS AFTWLGYVNS
AVNPIIYTTF NIEFRKAFMK ILHC


Related products :

Catalog number Product name Quantity
EIAAB11914 D(1B) dopamine receptor,D(5) dopamine receptor,D1beta dopamine receptor,Dopamine D5 receptor,DRD1B,DRD1L2,DRD5,Homo sapiens,Human
EIAAB11910 D(2C) dopamine receptor,D(4) dopamine receptor,Dopamine D4 receptor,DRD4,Homo sapiens,Human
EIAAB11912 Bos taurus,Bovine,D(1B) dopamine receptor,D(5) dopamine receptor,Dopamine D5 receptor,DRD1B,DRD5
EIAAB11911 D(2C) dopamine receptor,D(4) dopamine receptor,Dopamine D4 receptor,Drd4,Mouse,Mus musculus
EIAAB11909 D(2C) dopamine receptor,D(4) dopamine receptor,Dopamine D4 receptor,Drd4,Rat,Rattus norvegicus
EIAAB11915 D(1B) dopamine receptor,D(5) dopamine receptor,Dopamine D5 receptor,Drd5,Mouse,Mus musculus
EIAAB11913 D(1B) dopamine receptor,D(5) dopamine receptor,Dopamine D5 receptor,Drd5,Rat,Rattus norvegicus
18-461-10678 D(1B) dopamine receptor - D(5) dopamine receptor; D1beta dopamine receptor Polyclonal 0.05 ml
E1299m ELISA D(1A) dopamine receptor,Dopamine D1 receptor,Drd1,Drd1a,Gpcr15,Mouse,Mus musculus 96T
E1299m ELISA kit D(1A) dopamine receptor,Dopamine D1 receptor,Drd1,Drd1a,Gpcr15,Mouse,Mus musculus 96T
U1299m CLIA D(1A) dopamine receptor,Dopamine D1 receptor,Drd1,Drd1a,Gpcr15,Mouse,Mus musculus 96T
E1299r ELISA D(1A) dopamine receptor,Dopamine D1 receptor,Drd1,Drd1a,Rat,Rattus norvegicus 96T
E0673h ELISA kit D(2) dopamine receptor,Dopamine D2 receptor,DRD2,Homo sapiens,Human 96T
E1299Rb ELISA D(1A) dopamine receptor,Dopamine D1 receptor,DRD1,Oryctolagus cuniculus,Rabbit 96T
E1299b ELISA kit Bos taurus,Bovine,D(1A) dopamine receptor,D1AR,Dopamine D1 receptor,DRD1 96T
E1299r ELISA kit D(1A) dopamine receptor,Dopamine D1 receptor,Drd1,Drd1a,Rat,Rattus norvegicus 96T
U1299r CLIA D(1A) dopamine receptor,Dopamine D1 receptor,Drd1,Drd1a,Rat,Rattus norvegicus 96T
U1299Rb CLIA D(1A) dopamine receptor,Dopamine D1 receptor,DRD1,Oryctolagus cuniculus,Rabbit 96T
U1299h CLIA D(1A) dopamine receptor,Dopamine D1 receptor,DRD1,Homo sapiens,Human 96T
18-783-77560 RABBIT ANTI HUMAN DOPAMINE RECEPTOR D2 & D3 (C-TERMINAL) - Dopamine D2 receptor Polyclonal 0.25 ml
E1299h ELISA kit D(1A) dopamine receptor,Dopamine D1 receptor,DRD1,Homo sapiens,Human 96T
U1299b CLIA Bos taurus,Bovine,D(1A) dopamine receptor,D1AR,Dopamine D1 receptor,DRD1 96T
E1299h ELISA D(1A) dopamine receptor,Dopamine D1 receptor,DRD1,Homo sapiens,Human 96T
U0673h CLIA D(2) dopamine receptor,Dopamine D2 receptor,DRD2,Homo sapiens,Human 96T
E0673h ELISA D(2) dopamine receptor,Dopamine D2 receptor,DRD2,Homo sapiens,Human 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur